Camgene Therapeutics Limited
14921810
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/09/2025
micro entity
Next accounts due
30/06/2027
Confirmation statement
Last: 06/06/2026
Due 20/06/2027
Industry
Officers
director · Since 23/09/2024
PROFESSOR
CANADIAN · UNITED KINGDOM
Also on 2 other boards
Peter Oliver Wharton Sexton
director · Since 29/09/2025
BRITISH · UNITED KINGDOM
Former
director · Resigned 29/09/2025
director · Resigned 31/05/2026
Dr Jiahua Wu
director · Resigned 29/06/2026
Persons with Significant Control
Former PSCs
Mr Arpan Desai
Ceased 23/10/2025
CompanyRankvs 3149+ SIC 72110 peers35
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
-£10k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£7k
Working capital
Current Assets
£781k
Current Liabilities
£788k
Fixed Assets
£11k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.99 | -£191k |
| 2024 | 15.57 | — |
Derived from filed accounts. Not audited figures.